References
- ABDEL-FATTAH, N.S., AHMED, N.S. (2011): Evaluation of mefloquine-praziquantel combination therapy in pre-patent and patent Schistosoma mansoni infection in mice. Sci Parasitol, 12(3):139–149
- ABDEL-HAFEEZ, E., KAMAL, A., ABDELGELIL, N., ABDEL-FATAH, M. (2015): Parasites transmitted to human by ingestion of different types of meat, El-Minia City, El-Minia Governorate, Egypt. J Egypt Soc Parasitol, 45(3): 671–680. DOI: 10.12816/0017935
- ABOU-SHADY, O.M., MOHAMMED, S.S., ATTIA, S.S., YUSUF, H.-A.S., HELMY, D.O. (2016): Therapeutic effect of mefloquine on Schistosoma mansoni in experimental infection in mice. J Parasit Dis, 40(2): 259–267. DOI: 10.1007/s12639-014-0489-4
- ABOU RAYIA, D.M., SAD, A.E., ASHOUR, D.S., OREIBY, R.M. (2017): Implication of artemisinin nematocidal activity on experimental trichinellosis: In vitro and in vivo studies. Parasitol Int, 66(2): 56–63. DOI: 10.1016/j.parint.2016.11.012
- AKIHO, H., DENG, Y., BLENERHASETT, P., KANBAYASHI, H., COLLINS, S.M. (2005): Mechanisms underlying the maintenance of muscle hyper contractility in a model of post-infective gut dysfunction. Gastroenterology, 129(1): 131–141. DOI: 10.1053/j.gastro.2005.03.049 ALY, N., SELEM, R., ZALAT, R., KHALIL, H., TALHA, B. (2017): An innovative repurposing of mefloquine; assessment of its therapeutic efficacy in treating Cryptosporidium parvum infection of both immunocompetent and immunocompromised mice. J Egypt Soc Parasitol, 47(2): 253–262. DOI: 10.12816/JESP.2017.77763
- ANDREWS, K.T., FISHER, G., SKINER-ADAMS, T.S. (2014): Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist, 4(2): 95–111. DOI: 10.1016/j.ijpddr.2014.02.002
- ATTIA, R., MAHMOUD, A., FARAG, H., MAKBOUL, R., MOHAMED, M., IBRAHEIM, Z. (2015): Effect of myrrh and thyme on Trichinella spiralis enteral and parenteral phases with inducible nitric oxide expression in mice. Mem Inst Oswaldo Cruz, 110(8): 1035–1041. DOI: 10.1590/0074-02760150295
- BAI, X., HU, X., LIU, X., TANG, B., LIU, M. (2017): Current research of trichinellosis in China. Front Microbiol, 8: 1–7. DOI: 10.3389/fmicb.2017.01472
- BALASUBRAMANIAN, A., TERAMOTO, T., KULKARNI, A.A., BHATTACHARJEE, A.K., PADMANABHAN, R. (2017): Antiviral activities of selected antimalarial against dengue virus type 2 and Zika virus. Antiviral Res, 137, 141–150. DOI: 10.1016/j.antiviral.2016.11.015
- BARNES, E.H., DOBSON, R.J., BARGER, I.A. (1995): Worm control and anthelmintic resistance: adventures with a model. In Parasitology Today (Vol. 11, Issue 2, pp. 56–63). Elsevier Current Trends. DOI: 10.1016/0169-4758(95)80117-0
- CAPO, V.A., DESPOMMIER, D.D., POLVERE, R.I. (1998): Trichinella spiralis: vascular endothelial growth factor is up-regulated within the nurse cell during the early phase of its formation. J Parasitol, 84(2): 209. PMID: 9576489
- CEBALLOS, L., KROLEWIECKI, A., JUÁREZ, M., MORENO, L., SCHAER, F., ALVAREZ, L.I., CIMINO, R., WALSON, J., LANUSE, C.E. (2018): Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers. PLoS Negl Trop Dis, 12(1): e0005945. DOI:10.1371/journal.pntd.0005945
- CODINA, A.V., GARCÍA, A., LEONARDI, D., VASCONI, M.D., DIMASO, R.J., LAMAS, M.C., HINRICHSEN, L.I. (2015): Efficacy of albendazole:β-cyclodextrin citrate in the parenteral stage of Trichinella spiralis infection. Int J Biol Macromol, 77, 203–206. DOI: 10.1016/j.ijbiomac.2015.02.049
- DAYAN, A.D. (2003): Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop, 86(2–3): 141–159. DOI: 10.1016/S0001-706X(03)00031-7
- DUN, I.J., WRIGHT, K.A. (1985): Cell injury caused by Trichinella spiralis in the mucosal epithelium of B10A mice. J Parasitol, 71(6): 757–766. DOI: 10.2307/3281709
- DYAB, A. (2019): Prevalence and histopathology of Trichinella Spiralis larvae of slaughtered pigs in Cairo Governorate, Egypt. J Egypt Soc Parasitol, 49(2): 439–442. DOI: 10.21608/JESP.2019.68187 ELGENDY, D.I., OTHMAN, A.A., HASBY SAD, M.A., SOLIMAN, N.A., MWAFY, S.E. (2020): Resveratrol reduces oxidative damage and inflammation in mice infected with Trichinella spiralis J Helminthol, 94, e140. DOI: 10.1017/S0022149X20000206
- ELMEHY, D.A., ISMAIL, H.I., SOLIMAN, N.A., AMER, B.S., ELKALINY, H.H., EL-EBIARY, A.A., GAMEA, G.A. (2021): Oxidative stress mediated apoptotic potential of mefloquine on experimental trichinellosis. Acta Trop, 213, 105760. DOI: 10.1016/j.actatropica.2020.105760
- FAKAHANY, A.F., YOUNIS, M.S., EL HAMSHARY, A.M., FOUAD, M., HASAN, M., ALI, H. (2014): Effect of mefloquine on worm burden and tegumental changes in experimental Schistosoma mansoni infection. J Microsc Ultrastruct, 2(1): 7–11. DOI: 10.1016/j.jmau.2014.03.001 GUTMAN, J., GREEN, M., DURAND, S., ROJAS, O.V., GANGULY, B., QUEZADA, W.M., UTZ, G.C., SLUTSKER, L., RUEBUSH, T.K., BACON, D.J. (2009): Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria. Malar J, 8(1): 58. DOI: 10.1186/14752875-8-58
- JIANG, P., WANG, Z.-Q., CUI, J., ZHANG, X. (2012): Comparison of artificial digestion and Baermann’s methods for detection of Trichinella spiralis pre-encapsulated larvae in muscles with low-level infections. Foodborne Pathog Dis, 9(1): 27–31. DOI: 10.1089/fpd.2011.0985
- KALAISELVAN, R., MOHANTA, G.P., MADHUSUDAN, S., MANA, P.K., MANAVALAN, R. (2007): Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques. Pharmazie, 62(8): 604–607. PMID: 17867556 KAMILI, C., KAKATAPAR THY, R.S., VATTIKUTTI, U.M., CHIDRAWAR, V., AMMINENI, S. (2017): Anti-proliferative and anti-angiogenic activities of ion-channel modulators: In-ovo, in-vitro and in-vivo study. Asian Pac J Trop Biomed, 7(6): 555–562. DOI: 10.1016/j.apjtb.2017.05.005
- KANG, Y.-J., JO, J.-O., CHO, M.-K., YU, H.-S., OCK, M. S., CHA, H.J. (2011): Trichinella spiralis infection induces angiogenic factor thymosin β4 expression. Vet Parasitol, 181(2–4): 222–228. DOI: 10.1016/j.vetpar.2011.03.058
- KEISER, J., CHOLLET, J., XIAO, S.H., MEI, J.Y., JIAO, P.Y., UTZINGER, J., TANER, M. (2009): Mefloquine-An amino alcohol with promising antischistosomal properties in mice. PLoS Negl Trop Dis, 3(1). DOI: 10.1371/journal.pntd.0000350
- KEISER, J., N’GUESAN, N. A., ADOUBRYN, K. D., SILUÉ, K.D., VOUNATSOU, P., HATZ, C., UTZINGER, J., N’GORAN, E.K. (2010): Efficacy and safety of mefloquine, artesunate, mefloquine‐artesunate, and praziquantel against Schistosoma haematobium : randomized, exploratory open‐label trial. Clin Infect Dis, 50(9): 1205–1213. DOI: 10.1086/651682
- KEISER, J., UTZINGER, J. (2012): Antimalarials in the treatment of schistosomiasis. Curr Pharm Des, 18(24): 3531–3538. PMID: 22607145
- KÜSTER, T., STADELMAN, B., HERMAN, C., SCHOLL, S., KEISER, J., HEMPHILL, A. (2011): In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. Antimicrob Agents Chemother, 55(2): 713–721. DOI: 10.1128/AAC.01392-10
- LIU, Y., CHEN, S., XUE, R., ZHAO, J., DI, M. (2016): Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway. Biochem Biophys Res Commun, 470(2): 350–355. DOI: 10.1016/j.bbrc.2016.01.046 LOOAREESUWAN, S., WHITE, N., WARELL, D., FORGO, I., DUBACH, U., RANALDER, U., SCHWARTZ, D. (1987): Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol, 24(1): 37–42. DOI: 10.1111/j.1365-2125.1987.tb03133.x
- MANECK, T., HAGGENMULLER, Y., KEISER, J. (2010): Morphological effects and tegumental alterations induced by mefloquine on Schistosomula and adult flukes of Schistosoma mansoni. Parasitology, 137(1): 85–98. DOI: 10.1017/S0031182009990965
- MATADAMAS-MARTÍNEZ, F., NOGUEDA-TORES, B., HERNÁNDEZ-CAMPOS, A., HERNÁNDEZ-LUIS, F., CASTILLO, R., MENDOZA, G., AMBROSIO, J.R., ANDRÉS-ANTONIO, G., YÉPEZ-MULIA, L. (2013): Analysis of the effect of a 2-(trifluoromethyl)-1H-benzimidazole derivative on Trichinella spiralis muscle larvae. Vet Parasitol, 194(2–4): 193–197. DOI: 10.1016/j.vetpar.2013.01.054
- MORSY, T.A., IBRAHIM, B.B., HARIDY, F.M., RIFAAT, M.M. (2000) Trichinella encysted larvae in slaughtered pigs in Cairo (1995–1999). J Egypt Soc Parasitol, 30(3): 753–760. PMID: 11198373
- NADA, S.M., MOHAMMAD, S.M., Moad1, H.S., EL-SHAFEY, M., AL-GHANDOUR, A.M. IBRAHIM, N. (2018): Therapeutic effect of Nigella sativa and ivermectin versus albendazole on experimental trichinellosis in mice. J Egypt Soc Parasitol, 48(1): 85–92. DOI: 10.12816/jesp.2018.77029
- NASEF, N.E., MOHARM, I.M., ATIA, A.F., BARAKAT, R.M., ABOU HUSEIN, N.M., MOHAMED, A.S. (2018): Therapeutic efficacy of chitosan nano-particles and albendazole in intestinal murine trichinellosis. J Egypt Soc Parasitol, 48(3): 493–502. DOI: 10.12816/jesp.2018.76543
- OTHMAN, A.A., SHOHEIB, Z.S. (2016): Detrimental effects of geldanamycin on adults and larvae of Trichinella spiralis Helminthologia, 53(2): 126–132. DOI: 10.1515/helmin-2016-0003
- OTHMAN, AHMAD A., ABOU RAYIA, D.M., ASHOUR, D.S., SAIED, E.M., ZINELDEEN, D.H., EL-EBIARY, A.A. (2016): Atorvastatin and metformin administration modulates experimental Trichinella spiralis infection. Parasitol Int, 65(2): 105–112. DOI: 10.1016/j.parint.2015.11.001
- PANIC, G., DUTHALER, U., SPEICH, B., KEISER, J. (2014): Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist, 4(3): 185–200. DOI: 10.1016/j.ijpddr.2014.07.002
- POZIO, E., SACHINI, D., SACHI, L., TAMBURINI, A., ALBERICI, F. (2001): Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clin Infect Dis, 812, 1–5. DOI: 10.1086/318707
- RODRIGUES-JUNIOR, V.S., VILLELA, A.D., GONÇALVES, R.S.B., ABBADI, B.L., TRINDADE, R.V., LÓPEZ-GAVÍN, A., TUDÓ, G., GONZÁLEZ-MARTÍN, J., BASO, L.A., DE SOUZA, M.V.N., CAMPOS, M.M., SANTOS, D.S. (2016): Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection. J Antimicrob Agents, 48(2): 203–207. DOI: 10.1016/j.ijantimicag.2016.04.029
- ROMERO, M., ARTIGIANI, R., COSTA, H., OSHIMA, C.T.F., MISZPUTEN, S., FRANCO, M. (2008): Evaluation of the immunoexpression of COX1, COX-2 and p53 in Crohn’s disease. Arq Gastroenterol, 45(4): 295–300. DOI: 10.1590/s0004-28032008000400007
- RUFENER, R., RITLER, D., ZIELINSKI, J., DICK, L., DA SILVA, E.T., DA SILVA ARAUJO, A., JOEKEL, D.E., CZOCK, D., GOEPFERT, C., MORAES, A.M., DE SOUZA, M.V.N., MÜLLER, J., MEVISSEN, M., HEMPHILL, A., LUNDSTRÖM-STADELMANN, B. (2018): Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis Int J Parasitol Drugs Drug Resist, 8(2): 331–340. DOI: 10.1016/j.ijpddr.2018.06.004
- SAAD, A.E., ASHOUR, D.S., ABOU RAYIA, D.M., BEDEER, A.E. (2016): Carbonic anhydrase enzyme as a potential therapeutic target for experimental trichinellosis. Parasitol Res, 115(6): 2331–2339. DOI: 10.1007/s00436-016-4982-9
- SANGSTER, N. (2001): Managing parasiticide resistance. Vet Parasitol, 98(1–3): 89–109. DOI: 10.1016/s0304-4017(01)00425-3
- SERNA, H., PORRAS, M., VERGARA, P. (2006): Mast cell stabilizer ketotifen [4-(1-Methyl-4-piperidylidene)-4 H -benzo[4,5]cyclohepta[1,2b]thiophen-10(9 H )-one Fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the Rat. J Pharmacol Exp Ther, 319(3): 1104–1111. DOI: 10.1124/jpet.106.104620
- SHALABY, M.A., MOGHAZY, F.M., SHALABY, H.A., NASR, S.M. (2010): Effect of methanolic extract of Balanites aegyptiaca fruits on enteral and parenteral stages of Trichinella spiralis in rats. Parasitol Res, 107(1): 17–25. DOI: 10.1007/s00436-010-1827-9
- SHARMA, N., THOMAS, S., GOLDEN, E.B., HOFMAN, F.M., CHEN, T.C., PETASIS, N.A., SCHÖNTHAL, A.H., LOUIE, S.G. (2012): Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett, 326(2): 143–154. DOI: 10.1016/j.canlet.2012.07.029
- SHOHEIB, Z.S., SHAMLOULA, M.M., ABDIN, A.A., SEGAI, O. (2006): Role Of α - chymotrypsin and colchicine as adjuvant therapy in experimental muscular trichinellosis : parasitological, biochemical & immunohistochemical study. Egypt J Med Microbiol, 15(4): 773–790 SINGH, N., YEH, P.J. (2017): Suppressive drug combinations and their potential to combat antibiotic resistance. J Antibiot, 70(11): 1033–1042. DOI: 10.1038/ja.2017.102
- SIRIYASATIEN, P., YINGYOURD, P., NUCHPRAYOON, S. (2003): Efficacy of albendazole against early and late stage of Trichinella spiralis infection in mice. J Med Assoc Thai, 86(2): 8257 – S262. PMID: 12929998
- VERCRUYSSE, J., SCHETTERS, T.P.M., KNOX, D.P., WILLADSEN, P., CLAEREBOUT, E. (2007): Control of parasitic disease using vaccines: an answer to drug resistance? Rev. sci. tech. Off. int. Epiz., 26(1): 105–115. DOI: 10.20506/rst.26.1.1728
- WALLER, P.J. (1997): Anthelmintic resistance. Vet Parasitol, 72(3–4): 391–412. DOI: 10.1016/S0304-4017(97)00107-6
- WASSOM, D.L., DOUGHERTY, D.A., DICK, T.A. (1988): Trichinella spiralis infections of inbred mice: immunologically specific responses induced by different Trichinella isolates. J Parasitol, 74(2): 283–287. DOI: 10.2307/3282457
- WONG, W., BAI, X.-C., SLEEBS, B.E., TRIGLIA, T., BROWN, A., THOMPSON, J.K., JACKSON, K.E., HANSSEN, E., MARAPANA , D.S., FERNANDEZ, I.S., RALPH, S.A., COWMAN, A.F., SCHERES, S.H. W., BAUM, J. (2017): Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat Microbiol, 2(6): 17031. DOI: 10.1038/nmicrobiol.2017.31
- WRANICZ, M.J., GUSTOWSKA, L., GABRYEL, P., KUCHARSKA, E., CABAJ, W. (1998): Trichinella spiralis: induction of the basophilic transformation of muscle cells by synchronous newborn larvae. Parasitol Res, 84(5): 403–407. DOI: 10.1007/s004360050418
- XIAO, S.H. (2013): Mefloquine, a new type of compound against Schistosomes and other helminths in experimental studies. Parasitol Res, 112(11): 3723–3740. DOI: 10.1007/s00436-013-3559-0 YADAV, A.K., TEMJENMONGLA. (2012): Efficacy of Lasia spinosa leaf extract in treating mice infected with Trichinella spiralis Parasitol Res, 110(1): 493–498. DOI: 10.1007/s00436-011-2551-9
- YOUSSEF, A.I., UGA, S. (2014): Review of parasitic zoonoses in Egypt. Trop Med Health, 42(1): 3–14. DOI: 10.2149/tmh.2013-23